Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.87 USD | +0.56% |
|
+0.26% | -7.15% |
05-23 | Supernus Pharmaceuticals Reports 'Clinical Utility' From Epilepsy Treatment Study | MT |
05-23 | Transcript : Supernus Pharmaceuticals, Inc. - Special Call |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.15% | 1.48B | |
+8.12% | 72.4B | |
+15.93% | 8.98B | |
-24.60% | 4.28B | |
+15.26% | 4.28B | |
+28.46% | 4.01B | |
+6.61% | 2.16B | |
-35.98% | 1.9B | |
+7.76% | 1.95B | |
-47.71% | 1.63B |
- Stock Market
- Equities
- SUPN Stock
- News Supernus Pharmaceuticals, Inc.
- Transcript : Supernus Pharmaceuticals, Inc. Presents at 36th Annual J.P. Morgan Healthcare Conference, Jan-10-2018 12